Saturday 17 October 2026
Export NAKA’s income statement to Excel — free account
KindlyMD, Inc.
NAKA Financial Capital Markets
KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024. In the quarter to June 2026, revenue grew 8,680.7%, EPS grew 52.5% and free cash flow fell 25.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.13
0.96
−11.87%
Follow NAKA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 4 | — |
+8 more TTM periods Free account |
| (342.78%) | (157.33%) | (20.21%) | (37.62%) | ||
| (194.52%) | (93.04%) | (14.23%) | (25.97%) | ||
ROIC |
(135.54%) | (61.16%) | (25.29%) | (2.05%) | |
Return on Tangible Assets |
276.64% | 154.01% | (666.87%) | 48.28% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(34.40) | (47.05) | (144.36) | (138.11) | |
Free Cash Flow |
(687.94) | (748.72) | (722.51) | (701.24) | |
Capital Expenditures |
(640.66) | (702.79) | (699.00) | (684.39) | |
| Other line items | |||||
Cash ROIC |
(269.27%) | (186.08%) | (134.97%) | (139.76%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
2.71 | 0.04 | 0.00 | 0.01 | |
Inventory Turnover |
0.00 | 0.00 | — | 0.00 | |
Average Days of Payables |
260.60 | 19,146.41 | 0.00 | 93,181.79 | |
Days of Inventory on Hand |
0.00 | 0.00 | — | 0.00 | |
Tax Rate |
(0.05) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
132.38% | 951.13% | 1,149.35% | 843.98% | |
Share Based Compensation of Revenue |
15.58% | 106.30% | 134.65% | 146.63% | |
Interest Coverage |
(30.82) | (28.77) | (28.21) | — | |
Operating CF/Net income |
0.11 | 0.16 | 0.45 | 0.19 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(5.73) | (163.33) | (218.04) | (672.22) | |
Revenue per Share |
1.99 | 0.27 | 0.45 | 0.39 | |
Operating CF per Share |
(2.36) | (2.89) | (4.70) | (3.32) | |
Capex per Share |
(32.03) | (44.17) | (139.66) | (134.79) | |
Capex to Sales |
16.10 | 162.39 | 313.48 | 345.55 |
Columns are period end dates